Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.NPJ Precision Oncology|May 24, 2024
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosisBehnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, et al.Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.Cancer Research|August 11, 2022
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast CancerKristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, et al.Biorxiv : the Preprint Server for Biology|December 9, 2024
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaquesPayal P Pratap, Christopher A Cottrell, James Quinn, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Focusing antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.Molecular Cancer Therapeutics|May 31, 2019
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast CancerSuryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R Sareddy, et al.NPJ Vaccines|August 20, 2025
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaquesPayal P Pratap, Christopher A Cottrell, James Quinn, et al.Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.Pageof 10